Description
SUSTANCIA: L-OMBRIX TAB
Presentación en frasco con 415 mL
LEZOMIV® 4 mg/5 mL es un medicamento de uso subcutáneo que contiene Ocrelizumab
Frasco ámpula con 440 mg de trastuzumab en solución inyectable
Tumores del estroma gastrointestinal (GIST) después del fracaso de imatinib y sunitinib
LEVOCETIRIZINA TAB. 5 MG. CAJA C/10 NORETISTERONA 50.00 MG ESTRADIOL 5.00 MG SUSTANCIA: L-OMBRIX TABSUSTANCIA: LEVOCETIRIZINA TAB. 5 MG. CAJA C 10 FABRICANTE: AMSA GENERICO
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
